id	sid	tid	token	lemma	pos
cord-301921-i1o18nmw	1	1	key	key	NN
cord-301921-i1o18nmw	1	2	:	:	:
cord-301921-i1o18nmw	1	3	cord-301921-i1o18nmw	cord-301921-i1o18nmw	NN
cord-301921-i1o18nmw	1	4	authors	author	NNS
cord-301921-i1o18nmw	1	5	:	:	:
cord-301921-i1o18nmw	1	6	Sernicola	Sernicola	NNP
cord-301921-i1o18nmw	1	7	,	,	,
cord-301921-i1o18nmw	1	8	Alvise	Alvise	NNP
cord-301921-i1o18nmw	1	9	;	;	:
cord-301921-i1o18nmw	1	10	Alaibac	Alaibac	NNP
cord-301921-i1o18nmw	1	11	,	,	,
cord-301921-i1o18nmw	1	12	Mauro	Mauro	NNP
cord-301921-i1o18nmw	1	13	title	title	NN
cord-301921-i1o18nmw	1	14	:	:	:
cord-301921-i1o18nmw	2	1	How	how	WRB
cord-301921-i1o18nmw	2	2	to	to	TO
cord-301921-i1o18nmw	2	3	Deal	deal	VB
cord-301921-i1o18nmw	2	4	With	with	IN
cord-301921-i1o18nmw	2	5	Post	post	JJ
cord-301921-i1o18nmw	2	6	-	-	JJ
cord-301921-i1o18nmw	2	7	viral	viral	JJ
cord-301921-i1o18nmw	2	8	Cutaneous	Cutaneous	NNP
cord-301921-i1o18nmw	2	9	Eruptions	Eruptions	NNPS
cord-301921-i1o18nmw	2	10	in	in	IN
cord-301921-i1o18nmw	2	11	the	the	DT
cord-301921-i1o18nmw	2	12	Era	era	NN
cord-301921-i1o18nmw	2	13	of	of	IN
cord-301921-i1o18nmw	2	14	Coronavirus	Coronavirus	NNP
cord-301921-i1o18nmw	2	15	Infection	Infection	NNP
cord-301921-i1o18nmw	2	16	date	date	NN
cord-301921-i1o18nmw	3	1	:	:	:
cord-301921-i1o18nmw	3	2	2020	2020	CD
cord-301921-i1o18nmw	3	3	-	-	HYPH
cord-301921-i1o18nmw	3	4	05	05	CD
cord-301921-i1o18nmw	3	5	-	-	HYPH
cord-301921-i1o18nmw	3	6	12	12	CD
cord-301921-i1o18nmw	3	7	journal	journal	NN
cord-301921-i1o18nmw	3	8	:	:	:
cord-301921-i1o18nmw	4	1	Front	Front	NNP
cord-301921-i1o18nmw	4	2	Med	Med	NNP
cord-301921-i1o18nmw	4	3	(	(	-LRB-
cord-301921-i1o18nmw	4	4	Lausanne	Lausanne	NNP
cord-301921-i1o18nmw	4	5	)	)	-RRB-
cord-301921-i1o18nmw	4	6	DOI	DOI	NNP
cord-301921-i1o18nmw	4	7	:	:	:
cord-301921-i1o18nmw	5	1	10.3389/	10.3389/	CD
cord-301921-i1o18nmw	6	1	fmed.2020.00224	fmed.2020.00224	NNP
cord-301921-i1o18nmw	6	2	sha	sha	NNP
cord-301921-i1o18nmw	6	3	:	:	:
cord-301921-i1o18nmw	7	1	e20ebada34aa9a9dea2af56ccfcf6c2cf9fe8bc7	e20ebada34aa9a9dea2af56ccfcf6c2cf9fe8bc7	NNP
cord-301921-i1o18nmw	7	2	doc_id	doc_id	NNP
cord-301921-i1o18nmw	7	3	:	:	:
cord-301921-i1o18nmw	8	1	301921	301921	CD
cord-301921-i1o18nmw	8	2	cord_uid	cord_uid	NNS
cord-301921-i1o18nmw	8	3	:	:	:
cord-301921-i1o18nmw	9	1	i1o18nmw	i1o18nmw	NNP
cord-301921-i1o18nmw	9	2	nan	nan	NNP
cord-301921-i1o18nmw	10	1	In	in	IN
cord-301921-i1o18nmw	10	2	the	the	DT
cord-301921-i1o18nmw	10	3	age	age	NN
cord-301921-i1o18nmw	10	4	of	of	IN
cord-301921-i1o18nmw	10	5	the	the	DT
cord-301921-i1o18nmw	10	6	coronavirus	coronavirus	NN
cord-301921-i1o18nmw	10	7	epidemic	epidemic	NN
cord-301921-i1o18nmw	10	8	,	,	,
cord-301921-i1o18nmw	10	9	the	the	DT
cord-301921-i1o18nmw	10	10	implementation	implementation	NN
cord-301921-i1o18nmw	10	11	of	of	IN
cord-301921-i1o18nmw	10	12	urgent	urgent	JJ
cord-301921-i1o18nmw	10	13	surveillance	surveillance	NN
cord-301921-i1o18nmw	10	14	measures	measure	NNS
cord-301921-i1o18nmw	10	15	is	be	VBZ
cord-301921-i1o18nmw	10	16	sorely	sorely	RB
cord-301921-i1o18nmw	10	17	needed	need	VBN
cord-301921-i1o18nmw	10	18	due	due	IN
cord-301921-i1o18nmw	10	19	to	to	IN
cord-301921-i1o18nmw	10	20	the	the	DT
cord-301921-i1o18nmw	10	21	lack	lack	NN
cord-301921-i1o18nmw	10	22	of	of	IN
cord-301921-i1o18nmw	10	23	treatment	treatment	NN
cord-301921-i1o18nmw	10	24	for	for	IN
cord-301921-i1o18nmw	10	25	coronaviruses	coronaviruse	NNS
cord-301921-i1o18nmw	10	26	and	and	CC
cord-301921-i1o18nmw	10	27	the	the	DT
cord-301921-i1o18nmw	10	28	risk	risk	NN
cord-301921-i1o18nmw	10	29	of	of	IN
cord-301921-i1o18nmw	10	30	transmission	transmission	NN
cord-301921-i1o18nmw	10	31	during	during	IN
cord-301921-i1o18nmw	10	32	the	the	DT
cord-301921-i1o18nmw	10	33	incubation	incubation	NN
cord-301921-i1o18nmw	10	34	period	period	NN
cord-301921-i1o18nmw	10	35	.	.	.
cord-301921-i1o18nmw	11	1	The	the	DT
cord-301921-i1o18nmw	11	2	risk	risk	NN
cord-301921-i1o18nmw	11	3	of	of	IN
cord-301921-i1o18nmw	11	4	severe	severe	JJ
cord-301921-i1o18nmw	11	5	acute	acute	JJ
cord-301921-i1o18nmw	11	6	respiratory	respiratory	JJ
cord-301921-i1o18nmw	11	7	syndrome	syndrome	NN
cord-301921-i1o18nmw	11	8	coronavirus	coronavirus	NN
cord-301921-i1o18nmw	11	9	2	2	CD
cord-301921-i1o18nmw	12	1	(	(	-LRB-
cord-301921-i1o18nmw	12	2	SARS	SARS	NNP
cord-301921-i1o18nmw	12	3	-	-	HYPH
cord-301921-i1o18nmw	12	4	CoV-2	CoV-2	NNP
cord-301921-i1o18nmw	12	5	)	)	-RRB-
cord-301921-i1o18nmw	12	6	transmission	transmission	NN
cord-301921-i1o18nmw	12	7	is	be	VBZ
cord-301921-i1o18nmw	12	8	a	a	DT
cord-301921-i1o18nmw	12	9	current	current	JJ
cord-301921-i1o18nmw	12	10	topic	topic	NN
cord-301921-i1o18nmw	12	11	of	of	IN
cord-301921-i1o18nmw	12	12	investigation	investigation	NN
cord-301921-i1o18nmw	12	13	and	and	CC
cord-301921-i1o18nmw	13	1	the	the	DT
cord-301921-i1o18nmw	13	2	extent	extent	NN
cord-301921-i1o18nmw	13	3	of	of	IN
cord-301921-i1o18nmw	13	4	transmission	transmission	NN
cord-301921-i1o18nmw	13	5	from	from	IN
cord-301921-i1o18nmw	13	6	individuals	individual	NNS
cord-301921-i1o18nmw	13	7	who	who	WP
cord-301921-i1o18nmw	13	8	are	be	VBP
cord-301921-i1o18nmw	13	9	asymptomatic	asymptomatic	JJ
cord-301921-i1o18nmw	13	10	or	or	CC
cord-301921-i1o18nmw	13	11	within	within	IN
cord-301921-i1o18nmw	13	12	the	the	DT
cord-301921-i1o18nmw	13	13	incubation	incubation	NN
cord-301921-i1o18nmw	13	14	period	period	NN
cord-301921-i1o18nmw	13	15	remains	remain	VBZ
cord-301921-i1o18nmw	13	16	to	to	TO
cord-301921-i1o18nmw	13	17	be	be	VB
cord-301921-i1o18nmw	13	18	understood	understand	VBN
cord-301921-i1o18nmw	13	19	(	(	-LRB-
cord-301921-i1o18nmw	13	20	1	1	CD
cord-301921-i1o18nmw	13	21	)	)	-RRB-
cord-301921-i1o18nmw	13	22	.	.	.
cord-301921-i1o18nmw	14	1	The	the	DT
cord-301921-i1o18nmw	14	2	implementation	implementation	NN
cord-301921-i1o18nmw	14	3	of	of	IN
cord-301921-i1o18nmw	14	4	serologic	serologic	JJ
cord-301921-i1o18nmw	14	5	screening	screening	NN
cord-301921-i1o18nmw	14	6	tests	test	NNS
cord-301921-i1o18nmw	14	7	is	be	VBZ
cord-301921-i1o18nmw	14	8	highly	highly	RB
cord-301921-i1o18nmw	14	9	anticipated	anticipate	VBN
cord-301921-i1o18nmw	14	10	(	(	-LRB-
cord-301921-i1o18nmw	14	11	2	2	CD
cord-301921-i1o18nmw	14	12	)	)	-RRB-
cord-301921-i1o18nmw	14	13	and	and	CC
cord-301921-i1o18nmw	14	14	expected	expect	VBD
cord-301921-i1o18nmw	14	15	to	to	TO
cord-301921-i1o18nmw	14	16	shed	shed	VB
cord-301921-i1o18nmw	14	17	light	light	NN
cord-301921-i1o18nmw	14	18	on	on	IN
cord-301921-i1o18nmw	14	19	the	the	DT
cord-301921-i1o18nmw	14	20	role	role	NN
cord-301921-i1o18nmw	14	21	of	of	IN
cord-301921-i1o18nmw	14	22	asymptomatic	asymptomatic	JJ
cord-301921-i1o18nmw	14	23	infections	infection	NNS
cord-301921-i1o18nmw	14	24	as	as	RB
cord-301921-i1o18nmw	14	25	well	well	RB
cord-301921-i1o18nmw	14	26	as	as	IN
cord-301921-i1o18nmw	14	27	support	support	VB
cord-301921-i1o18nmw	14	28	the	the	DT
cord-301921-i1o18nmw	14	29	importance	importance	NN
cord-301921-i1o18nmw	14	30	of	of	IN
cord-301921-i1o18nmw	14	31	detecting	detect	VBG
cord-301921-i1o18nmw	14	32	subjects	subject	NNS
cord-301921-i1o18nmw	14	33	that	that	WDT
cord-301921-i1o18nmw	14	34	are	be	VBP
cord-301921-i1o18nmw	14	35	asymptomatic	asymptomatic	JJ
cord-301921-i1o18nmw	14	36	or	or	CC
cord-301921-i1o18nmw	14	37	those	those	DT
cord-301921-i1o18nmw	14	38	that	that	WDT
cord-301921-i1o18nmw	14	39	have	have	VBP
cord-301921-i1o18nmw	14	40	mild	mild	JJ
cord-301921-i1o18nmw	14	41	symptoms	symptom	NNS
cord-301921-i1o18nmw	14	42	.	.	.
cord-301921-i1o18nmw	15	1	These	these	DT
cord-301921-i1o18nmw	15	2	individuals	individual	NNS
cord-301921-i1o18nmw	15	3	remain	remain	VBP
cord-301921-i1o18nmw	15	4	undetected	undetected	JJ
cord-301921-i1o18nmw	15	5	and	and	CC
cord-301921-i1o18nmw	15	6	complicate	complicate	VB
cord-301921-i1o18nmw	15	7	the	the	DT
cord-301921-i1o18nmw	15	8	efforts	effort	NNS
cord-301921-i1o18nmw	15	9	made	make	VBN
cord-301921-i1o18nmw	15	10	to	to	TO
cord-301921-i1o18nmw	15	11	control	control	VB
cord-301921-i1o18nmw	15	12	the	the	DT
cord-301921-i1o18nmw	15	13	spread	spread	NN
cord-301921-i1o18nmw	15	14	of	of	IN
cord-301921-i1o18nmw	15	15	the	the	DT
cord-301921-i1o18nmw	15	16	disease	disease	NN
cord-301921-i1o18nmw	15	17	(	(	-LRB-
cord-301921-i1o18nmw	15	18	3	3	CD
cord-301921-i1o18nmw	15	19	)	)	-RRB-
cord-301921-i1o18nmw	15	20	.	.	.
cord-301921-i1o18nmw	16	1	According	accord	VBG
cord-301921-i1o18nmw	16	2	to	to	IN
cord-301921-i1o18nmw	16	3	recent	recent	JJ
cord-301921-i1o18nmw	16	4	reports	report	NNS
cord-301921-i1o18nmw	16	5	,	,	,
cord-301921-i1o18nmw	16	6	up	up	IN
cord-301921-i1o18nmw	16	7	to	to	TO
cord-301921-i1o18nmw	16	8	51	51	CD
cord-301921-i1o18nmw	16	9	%	%	NN
cord-301921-i1o18nmw	16	10	of	of	IN
cord-301921-i1o18nmw	16	11	confirmed	confirm	VBN
cord-301921-i1o18nmw	16	12	cases	case	NNS
cord-301921-i1o18nmw	16	13	may	may	MD
cord-301921-i1o18nmw	16	14	be	be	VB
cord-301921-i1o18nmw	16	15	asymptomatic	asymptomatic	JJ
cord-301921-i1o18nmw	16	16	at	at	IN
cord-301921-i1o18nmw	16	17	the	the	DT
cord-301921-i1o18nmw	16	18	time	time	NN
cord-301921-i1o18nmw	16	19	of	of	IN
cord-301921-i1o18nmw	16	20	diagnosis	diagnosis	NN
cord-301921-i1o18nmw	16	21	(	(	-LRB-
cord-301921-i1o18nmw	16	22	4	4	CD
cord-301921-i1o18nmw	16	23	)	)	-RRB-
cord-301921-i1o18nmw	16	24	,	,	,
cord-301921-i1o18nmw	16	25	accounting	account	VBG
cord-301921-i1o18nmw	16	26	for	for	IN
cord-301921-i1o18nmw	16	27	silent	silent	JJ
cord-301921-i1o18nmw	16	28	infection	infection	NN
cord-301921-i1o18nmw	16	29	and	and	CC
cord-301921-i1o18nmw	16	30	the	the	DT
cord-301921-i1o18nmw	16	31	incubation	incubation	NN
cord-301921-i1o18nmw	16	32	period	period	NN
cord-301921-i1o18nmw	16	33	.	.	.
cord-301921-i1o18nmw	17	1	The	the	DT
cord-301921-i1o18nmw	17	2	latter	latter	JJ
cord-301921-i1o18nmw	17	3	is	be	VBZ
cord-301921-i1o18nmw	17	4	reported	report	VBN
cord-301921-i1o18nmw	17	5	to	to	TO
cord-301921-i1o18nmw	17	6	last	last	VB
cord-301921-i1o18nmw	17	7	a	a	DT
cord-301921-i1o18nmw	17	8	median	median	NN
cord-301921-i1o18nmw	17	9	of	of	IN
cord-301921-i1o18nmw	17	10	4	4	CD
cord-301921-i1o18nmw	17	11	(	(	-LRB-
cord-301921-i1o18nmw	17	12	5	5	CD
cord-301921-i1o18nmw	17	13	)	)	-RRB-
cord-301921-i1o18nmw	17	14	or	or	CC
cord-301921-i1o18nmw	17	15	5.2	5.2	CD
cord-301921-i1o18nmw	17	16	days	day	NNS
cord-301921-i1o18nmw	17	17	(	(	-LRB-
cord-301921-i1o18nmw	17	18	6	6	CD
cord-301921-i1o18nmw	17	19	)	)	-RRB-
cord-301921-i1o18nmw	17	20	following	follow	VBG
cord-301921-i1o18nmw	17	21	infection	infection	NN
cord-301921-i1o18nmw	17	22	,	,	,
cord-301921-i1o18nmw	17	23	with	with	IN
cord-301921-i1o18nmw	17	24	onset	onset	NN
cord-301921-i1o18nmw	17	25	of	of	IN
cord-301921-i1o18nmw	17	26	disease	disease	NN
cord-301921-i1o18nmw	17	27	within	within	IN
cord-301921-i1o18nmw	17	28	14	14	CD
cord-301921-i1o18nmw	17	29	days	day	NNS
cord-301921-i1o18nmw	17	30	.	.	.
cord-301921-i1o18nmw	18	1	How	how	WRB
cord-301921-i1o18nmw	18	2	can	can	MD
cord-301921-i1o18nmw	18	3	dermatologists	dermatologist	NNS
cord-301921-i1o18nmw	18	4	contribute	contribute	VB
cord-301921-i1o18nmw	18	5	to	to	IN
cord-301921-i1o18nmw	18	6	health	health	NN
cord-301921-i1o18nmw	18	7	surveillance	surveillance	NN
cord-301921-i1o18nmw	18	8	during	during	IN
cord-301921-i1o18nmw	18	9	the	the	DT
cord-301921-i1o18nmw	18	10	coronavirus	coronavirus	NN
cord-301921-i1o18nmw	18	11	outbreak	outbreak	NN
cord-301921-i1o18nmw	18	12	?	?	.
cord-301921-i1o18nmw	19	1	A	a	DT
cord-301921-i1o18nmw	19	2	recent	recent	JJ
cord-301921-i1o18nmw	19	3	single	single	JJ
cord-301921-i1o18nmw	19	4	center	center	NN
cord-301921-i1o18nmw	19	5	report	report	NN
cord-301921-i1o18nmw	19	6	from	from	IN
cord-301921-i1o18nmw	19	7	Italy	Italy	NNP
cord-301921-i1o18nmw	19	8	provided	provide	VBD
cord-301921-i1o18nmw	19	9	the	the	DT
cord-301921-i1o18nmw	19	10	first	first	JJ
cord-301921-i1o18nmw	19	11	epidemiological	epidemiological	JJ
cord-301921-i1o18nmw	19	12	data	datum	NNS
cord-301921-i1o18nmw	19	13	on	on	IN
cord-301921-i1o18nmw	19	14	the	the	DT
cord-301921-i1o18nmw	19	15	skin	skin	NN
cord-301921-i1o18nmw	19	16	's	's	POS
cord-301921-i1o18nmw	19	17	involvement	involvement	NN
cord-301921-i1o18nmw	19	18	in	in	IN
cord-301921-i1o18nmw	19	19	88	88	CD
cord-301921-i1o18nmw	19	20	hospitalized	hospitalize	VBN
cord-301921-i1o18nmw	19	21	patients	patient	NNS
cord-301921-i1o18nmw	19	22	with	with	IN
cord-301921-i1o18nmw	19	23	COVID-19	COVID-19	NNP
cord-301921-i1o18nmw	19	24	(	(	-LRB-
cord-301921-i1o18nmw	19	25	7	7	CD
cord-301921-i1o18nmw	19	26	)	)	-RRB-
cord-301921-i1o18nmw	19	27	.	.	.
cord-301921-i1o18nmw	20	1	Eighteen	eighteen	CD
cord-301921-i1o18nmw	20	2	patients	patient	NNS
cord-301921-i1o18nmw	20	3	(	(	-LRB-
cord-301921-i1o18nmw	20	4	20.4	20.4	CD
cord-301921-i1o18nmw	20	5	%	%	NN
cord-301921-i1o18nmw	20	6	)	)	-RRB-
cord-301921-i1o18nmw	20	7	,	,	,
cord-301921-i1o18nmw	20	8	with	with	IN
cord-301921-i1o18nmw	20	9	a	a	DT
cord-301921-i1o18nmw	20	10	positive	positive	JJ
cord-301921-i1o18nmw	20	11	virology	virology	NN
cord-301921-i1o18nmw	20	12	and	and	CC
cord-301921-i1o18nmw	20	13	no	no	DT
cord-301921-i1o18nmw	20	14	history	history	NN
cord-301921-i1o18nmw	20	15	of	of	IN
cord-301921-i1o18nmw	20	16	recent	recent	JJ
cord-301921-i1o18nmw	20	17	drug	drug	NN
cord-301921-i1o18nmw	20	18	intake	intake	NN
cord-301921-i1o18nmw	20	19	,	,	,
cord-301921-i1o18nmw	20	20	developed	develop	VBD
cord-301921-i1o18nmw	20	21	skin	skin	NN
cord-301921-i1o18nmw	20	22	manifestations	manifestation	NNS
cord-301921-i1o18nmw	20	23	.	.	.
cord-301921-i1o18nmw	21	1	Eight	eight	CD
cord-301921-i1o18nmw	21	2	patients	patient	NNS
cord-301921-i1o18nmw	21	3	developed	develop	VBD
cord-301921-i1o18nmw	21	4	cutaneous	cutaneous	JJ
cord-301921-i1o18nmw	21	5	involvement	involvement	NN
cord-301921-i1o18nmw	21	6	at	at	IN
cord-301921-i1o18nmw	21	7	the	the	DT
cord-301921-i1o18nmw	21	8	onset	onset	NN
cord-301921-i1o18nmw	21	9	of	of	IN
cord-301921-i1o18nmw	21	10	disease	disease	NN
cord-301921-i1o18nmw	21	11	and	and	CC
cord-301921-i1o18nmw	21	12	10	10	CD
cord-301921-i1o18nmw	21	13	patients	patient	NNS
cord-301921-i1o18nmw	21	14	developed	develop	VBD
cord-301921-i1o18nmw	21	15	cutaneous	cutaneous	JJ
cord-301921-i1o18nmw	21	16	involvement	involvement	NN
cord-301921-i1o18nmw	21	17	after	after	IN
cord-301921-i1o18nmw	21	18	hospitalization	hospitalization	NN
cord-301921-i1o18nmw	21	19	.	.	.
cord-301921-i1o18nmw	22	1	Reported	report	VBN
cord-301921-i1o18nmw	22	2	skin	skin	NN
cord-301921-i1o18nmw	22	3	involvement	involvement	NN
cord-301921-i1o18nmw	22	4	was	be	VBD
cord-301921-i1o18nmw	22	5	consistent	consistent	JJ
cord-301921-i1o18nmw	22	6	with	with	IN
cord-301921-i1o18nmw	22	7	that	that	DT
cord-301921-i1o18nmw	22	8	commonly	commonly	RB
cord-301921-i1o18nmw	22	9	observed	observe	VBN
cord-301921-i1o18nmw	22	10	during	during	IN
cord-301921-i1o18nmw	22	11	viral	viral	JJ
cord-301921-i1o18nmw	22	12	infections	infection	NNS
cord-301921-i1o18nmw	22	13	and	and	CC
cord-301921-i1o18nmw	22	14	was	be	VBD
cord-301921-i1o18nmw	22	15	described	describe	VBN
cord-301921-i1o18nmw	22	16	as	as	IN
cord-301921-i1o18nmw	22	17	an	an	DT
cord-301921-i1o18nmw	22	18	erythematous	erythematous	JJ
cord-301921-i1o18nmw	22	19	rash	rash	NN
cord-301921-i1o18nmw	22	20	in	in	IN
cord-301921-i1o18nmw	22	21	14	14	CD
cord-301921-i1o18nmw	22	22	patients	patient	NNS
cord-301921-i1o18nmw	22	23	,	,	,
cord-301921-i1o18nmw	22	24	a	a	DT
cord-301921-i1o18nmw	22	25	urticarial	urticarial	JJ
cord-301921-i1o18nmw	22	26	rash	rash	NN
cord-301921-i1o18nmw	22	27	in	in	IN
cord-301921-i1o18nmw	22	28	three	three	CD
cord-301921-i1o18nmw	22	29	patients	patient	NNS
cord-301921-i1o18nmw	22	30	,	,	,
cord-301921-i1o18nmw	22	31	and	and	CC
cord-301921-i1o18nmw	22	32	a	a	DT
cord-301921-i1o18nmw	22	33	chickenpox	chickenpox	NN
cord-301921-i1o18nmw	22	34	-	-	HYPH
cord-301921-i1o18nmw	22	35	like	like	JJ
cord-301921-i1o18nmw	22	36	vesicular	vesicular	JJ
cord-301921-i1o18nmw	22	37	rash	rash	NN
cord-301921-i1o18nmw	22	38	in	in	IN
cord-301921-i1o18nmw	22	39	one	one	CD
cord-301921-i1o18nmw	22	40	subject	subject	NN
cord-301921-i1o18nmw	22	41	.	.	.
cord-301921-i1o18nmw	23	1	According	accord	VBG
cord-301921-i1o18nmw	23	2	to	to	IN
cord-301921-i1o18nmw	23	3	the	the	DT
cord-301921-i1o18nmw	23	4	author	author	NN
cord-301921-i1o18nmw	23	5	,	,	,
cord-301921-i1o18nmw	23	6	cutaneous	cutaneous	JJ
cord-301921-i1o18nmw	23	7	signs	sign	NNS
cord-301921-i1o18nmw	23	8	were	be	VBD
cord-301921-i1o18nmw	23	9	not	not	RB
cord-301921-i1o18nmw	23	10	relatable	relatable	JJ
cord-301921-i1o18nmw	23	11	to	to	IN
cord-301921-i1o18nmw	23	12	the	the	DT
cord-301921-i1o18nmw	23	13	severity	severity	NN
cord-301921-i1o18nmw	23	14	of	of	IN
cord-301921-i1o18nmw	23	15	the	the	DT
cord-301921-i1o18nmw	23	16	systemic	systemic	JJ
cord-301921-i1o18nmw	23	17	disease	disease	NN
cord-301921-i1o18nmw	23	18	.	.	.
cord-301921-i1o18nmw	24	1	Shortly	shortly	RB
cord-301921-i1o18nmw	24	2	thereafter	thereafter	RB
cord-301921-i1o18nmw	24	3	,	,	,
cord-301921-i1o18nmw	24	4	in	in	IN
cord-301921-i1o18nmw	24	5	a	a	DT
cord-301921-i1o18nmw	24	6	Chinese	chinese	JJ
cord-301921-i1o18nmw	24	7	series	series	NN
cord-301921-i1o18nmw	24	8	of	of	IN
cord-301921-i1o18nmw	24	9	seven	seven	CD
cord-301921-i1o18nmw	24	10	critical	critical	JJ
cord-301921-i1o18nmw	24	11	COVID-19	COVID-19	NNP
cord-301921-i1o18nmw	24	12	patients	patient	NNS
cord-301921-i1o18nmw	24	13	,	,	,
cord-301921-i1o18nmw	24	14	acral	acral	JJ
cord-301921-i1o18nmw	24	15	ischemia	ischemia	NN
cord-301921-i1o18nmw	24	16	presenting	present	VBG
cord-301921-i1o18nmw	24	17	as	as	IN
cord-301921-i1o18nmw	24	18	cyanosis	cyanosis	NN
cord-301921-i1o18nmw	24	19	of	of	IN
cord-301921-i1o18nmw	24	20	fingers	finger	NNS
cord-301921-i1o18nmw	24	21	and	and	CC
cord-301921-i1o18nmw	24	22	toes	toe	NNS
cord-301921-i1o18nmw	24	23	with	with	IN
cord-301921-i1o18nmw	24	24	blisters	blister	NNS
cord-301921-i1o18nmw	24	25	and	and	CC
cord-301921-i1o18nmw	24	26	gangrene	gangrene	NN
cord-301921-i1o18nmw	24	27	was	be	VBD
cord-301921-i1o18nmw	24	28	reported	report	VBN
cord-301921-i1o18nmw	24	29	in	in	IN
cord-301921-i1o18nmw	24	30	all	all	DT
cord-301921-i1o18nmw	24	31	subjects	subject	NNS
cord-301921-i1o18nmw	24	32	and	and	CC
cord-301921-i1o18nmw	24	33	correlated	correlate	VBD
cord-301921-i1o18nmw	24	34	to	to	IN
cord-301921-i1o18nmw	24	35	an	an	DT
cord-301921-i1o18nmw	24	36	hypercoagulative	hypercoagulative	JJ
cord-301921-i1o18nmw	24	37	state	state	NN
cord-301921-i1o18nmw	24	38	secondary	secondary	JJ
cord-301921-i1o18nmw	24	39	to	to	IN
cord-301921-i1o18nmw	24	40	viral	viral	JJ
cord-301921-i1o18nmw	24	41	infection	infection	NN
cord-301921-i1o18nmw	24	42	(	(	-LRB-
cord-301921-i1o18nmw	24	43	8)	8)	NNP
cord-301921-i1o18nmw	24	44	.	.	.
cord-301921-i1o18nmw	25	1	Presently	presently	RB
cord-301921-i1o18nmw	25	2	,	,	,
cord-301921-i1o18nmw	25	3	an	an	DT
cord-301921-i1o18nmw	25	4	unusual	unusual	JJ
cord-301921-i1o18nmw	25	5	occurrence	occurrence	NN
cord-301921-i1o18nmw	25	6	of	of	IN
cord-301921-i1o18nmw	25	7	acral	acral	JJ
cord-301921-i1o18nmw	25	8	ischemic	ischemic	JJ
cord-301921-i1o18nmw	25	9	lesions	lesion	NNS
cord-301921-i1o18nmw	25	10	is	be	VBZ
cord-301921-i1o18nmw	25	11	being	be	VBG
cord-301921-i1o18nmw	25	12	reported	report	VBN
cord-301921-i1o18nmw	25	13	in	in	IN
cord-301921-i1o18nmw	25	14	Italy	Italy	NNP
cord-301921-i1o18nmw	25	15	in	in	IN
cord-301921-i1o18nmw	25	16	a	a	DT
cord-301921-i1o18nmw	25	17	growing	grow	VBG
cord-301921-i1o18nmw	25	18	number	number	NN
cord-301921-i1o18nmw	25	19	of	of	IN
cord-301921-i1o18nmw	25	20	apparently	apparently	RB
cord-301921-i1o18nmw	25	21	healthy	healthy	JJ
cord-301921-i1o18nmw	25	22	children	child	NNS
cord-301921-i1o18nmw	25	23	,	,	,
cord-301921-i1o18nmw	25	24	adolescents	adolescent	NNS
cord-301921-i1o18nmw	25	25	,	,	,
cord-301921-i1o18nmw	25	26	and	and	CC
cord-301921-i1o18nmw	25	27	young	young	JJ
cord-301921-i1o18nmw	25	28	adults	adult	NNS
cord-301921-i1o18nmw	25	29	.	.	.
cord-301921-i1o18nmw	26	1	Whether	whether	IN
cord-301921-i1o18nmw	26	2	these	these	DT
cord-301921-i1o18nmw	26	3	lesions	lesion	NNS
cord-301921-i1o18nmw	26	4	could	could	MD
cord-301921-i1o18nmw	26	5	be	be	VB
cord-301921-i1o18nmw	26	6	due	due	JJ
cord-301921-i1o18nmw	26	7	to	to	IN
cord-301921-i1o18nmw	26	8	virally	virally	RB
cord-301921-i1o18nmw	26	9	induced	induce	VBN
cord-301921-i1o18nmw	26	10	microvascular	microvascular	JJ
cord-301921-i1o18nmw	26	11	thrombosis	thrombosis	NN
cord-301921-i1o18nmw	26	12	and	and	CC
cord-301921-i1o18nmw	26	13	endothelial	endothelial	JJ
cord-301921-i1o18nmw	26	14	damage	damage	NN
cord-301921-i1o18nmw	26	15	remains	remain	VBZ
cord-301921-i1o18nmw	26	16	speculative	speculative	JJ
cord-301921-i1o18nmw	26	17	and	and	CC
cord-301921-i1o18nmw	26	18	is	be	VBZ
cord-301921-i1o18nmw	26	19	supported	support	VBN
cord-301921-i1o18nmw	26	20	by	by	IN
cord-301921-i1o18nmw	26	21	positive	positive	JJ
cord-301921-i1o18nmw	26	22	viral	viral	JJ
cord-301921-i1o18nmw	26	23	swabs	swab	NNS
cord-301921-i1o18nmw	26	24	in	in	IN
cord-301921-i1o18nmw	26	25	two	two	CD
cord-301921-i1o18nmw	26	26	cases	case	NNS
cord-301921-i1o18nmw	26	27	and	and	CC
cord-301921-i1o18nmw	26	28	by	by	IN
cord-301921-i1o18nmw	26	29	a	a	DT
cord-301921-i1o18nmw	26	30	suspicious	suspicious	JJ
cord-301921-i1o18nmw	26	31	family	family	NN
cord-301921-i1o18nmw	26	32	history	history	NN
cord-301921-i1o18nmw	26	33	in	in	IN
cord-301921-i1o18nmw	26	34	the	the	DT
cord-301921-i1o18nmw	26	35	remaining	remain	VBG
cord-301921-i1o18nmw	26	36	reports	report	NNS
cord-301921-i1o18nmw	26	37	(	(	-LRB-
cord-301921-i1o18nmw	26	38	9	9	CD
cord-301921-i1o18nmw	26	39	)	)	-RRB-
cord-301921-i1o18nmw	26	40	.	.	.
cord-301921-i1o18nmw	27	1	In	in	IN
cord-301921-i1o18nmw	27	2	our	-PRON-	PRP$
cord-301921-i1o18nmw	27	3	routine	routine	JJ
cord-301921-i1o18nmw	27	4	clinical	clinical	JJ
cord-301921-i1o18nmw	27	5	practice	practice	NN
cord-301921-i1o18nmw	27	6	during	during	IN
cord-301921-i1o18nmw	27	7	the	the	DT
cord-301921-i1o18nmw	27	8	COVID-19	covid-19	JJ
cord-301921-i1o18nmw	27	9	outbreak	outbreak	NN
cord-301921-i1o18nmw	27	10	,	,	,
cord-301921-i1o18nmw	27	11	we	-PRON-	PRP
cord-301921-i1o18nmw	27	12	are	be	VBP
cord-301921-i1o18nmw	27	13	observing	observe	VBG
cord-301921-i1o18nmw	27	14	a	a	DT
cord-301921-i1o18nmw	27	15	growing	grow	VBG
cord-301921-i1o18nmw	27	16	number	number	NN
cord-301921-i1o18nmw	27	17	of	of	IN
cord-301921-i1o18nmw	27	18	post	post	JJ
cord-301921-i1o18nmw	27	19	viral	viral	JJ
cord-301921-i1o18nmw	27	20	cutaneous	cutaneous	JJ
cord-301921-i1o18nmw	27	21	eruptions	eruption	NNS
cord-301921-i1o18nmw	27	22	in	in	IN
cord-301921-i1o18nmw	27	23	apparently	apparently	RB
cord-301921-i1o18nmw	27	24	healthy	healthy	JJ
cord-301921-i1o18nmw	27	25	individuals	individual	NNS
cord-301921-i1o18nmw	27	26	in	in	IN
cord-301921-i1o18nmw	27	27	the	the	DT
cord-301921-i1o18nmw	27	28	second	second	JJ
cord-301921-i1o18nmw	27	29	or	or	CC
cord-301921-i1o18nmw	27	30	third	third	JJ
cord-301921-i1o18nmw	27	31	decade	decade	NN
cord-301921-i1o18nmw	27	32	of	of	IN
cord-301921-i1o18nmw	27	33	life	life	NN
cord-301921-i1o18nmw	27	34	that	that	WDT
cord-301921-i1o18nmw	27	35	we	-PRON-	PRP
cord-301921-i1o18nmw	27	36	feel	feel	VBP
cord-301921-i1o18nmw	27	37	is	be	VBZ
cord-301921-i1o18nmw	27	38	remarkable	remarkable	JJ
cord-301921-i1o18nmw	27	39	compared	compare	VBN
cord-301921-i1o18nmw	27	40	to	to	IN
cord-301921-i1o18nmw	27	41	the	the	DT
cord-301921-i1o18nmw	27	42	usual	usual	JJ
cord-301921-i1o18nmw	27	43	local	local	JJ
cord-301921-i1o18nmw	27	44	epidemiology	epidemiology	NN
cord-301921-i1o18nmw	27	45	of	of	IN
cord-301921-i1o18nmw	27	46	this	this	DT
cord-301921-i1o18nmw	27	47	season	season	NN
cord-301921-i1o18nmw	27	48	.	.	.
cord-301921-i1o18nmw	28	1	We	-PRON-	PRP
cord-301921-i1o18nmw	28	2	observed	observe	VBD
cord-301921-i1o18nmw	28	3	multiple	multiple	JJ
cord-301921-i1o18nmw	28	4	rounded	rounded	JJ
cord-301921-i1o18nmw	28	5	erythematous	erythematous	JJ
cord-301921-i1o18nmw	28	6	-	-	HYPH
cord-301921-i1o18nmw	28	7	violaceous	violaceous	JJ
cord-301921-i1o18nmw	28	8	lesions	lesion	NNS
cord-301921-i1o18nmw	28	9	appearing	appear	VBG
cord-301921-i1o18nmw	28	10	on	on	IN
cord-301921-i1o18nmw	28	11	the	the	DT
cord-301921-i1o18nmw	28	12	dorsal	dorsal	JJ
cord-301921-i1o18nmw	28	13	and	and	CC
cord-301921-i1o18nmw	28	14	palmar	palmar	NN
cord-301921-i1o18nmw	28	15	aspect	aspect	NN
cord-301921-i1o18nmw	28	16	of	of	IN
cord-301921-i1o18nmw	28	17	the	the	DT
cord-301921-i1o18nmw	28	18	fingers	finger	NNS
cord-301921-i1o18nmw	28	19	(	(	-LRB-
cord-301921-i1o18nmw	28	20	Figure	figure	NN
cord-301921-i1o18nmw	28	21	1	1	CD
cord-301921-i1o18nmw	28	22	)	)	-RRB-
cord-301921-i1o18nmw	28	23	of	of	IN
cord-301921-i1o18nmw	28	24	adolescent	adolescent	JJ
cord-301921-i1o18nmw	28	25	/	/	SYM
cord-301921-i1o18nmw	28	26	young	young	JJ
cord-301921-i1o18nmw	28	27	patients	patient	NNS
cord-301921-i1o18nmw	28	28	of	of	IN
cord-301921-i1o18nmw	28	29	both	both	DT
cord-301921-i1o18nmw	28	30	sexes	sex	NNS
cord-301921-i1o18nmw	28	31	that	that	WDT
cord-301921-i1o18nmw	28	32	were	be	VBD
cord-301921-i1o18nmw	28	33	asymptomatic	asymptomatic	JJ
cord-301921-i1o18nmw	28	34	or	or	CC
cord-301921-i1o18nmw	28	35	minimally	minimally	RB
cord-301921-i1o18nmw	28	36	symptomatic	symptomatic	JJ
cord-301921-i1o18nmw	28	37	for	for	IN
cord-301921-i1o18nmw	28	38	airway	airway	NN
cord-301921-i1o18nmw	28	39	disease	disease	NN
cord-301921-i1o18nmw	28	40	.	.	.
cord-301921-i1o18nmw	29	1	We	-PRON-	PRP
cord-301921-i1o18nmw	29	2	initially	initially	RB
cord-301921-i1o18nmw	29	3	interpreted	interpret	VBD
cord-301921-i1o18nmw	29	4	the	the	DT
cord-301921-i1o18nmw	29	5	lesions	lesion	NNS
cord-301921-i1o18nmw	29	6	as	as	IN
cord-301921-i1o18nmw	29	7	an	an	DT
cord-301921-i1o18nmw	29	8	erythema	erythema	JJ
cord-301921-i1o18nmw	29	9	multiforme	multiforme	NN
cord-301921-i1o18nmw	29	10	-	-	HYPH
cord-301921-i1o18nmw	29	11	like	like	JJ
cord-301921-i1o18nmw	29	12	eruption	eruption	NN
cord-301921-i1o18nmw	29	13	,	,	,
cord-301921-i1o18nmw	29	14	due	due	IN
cord-301921-i1o18nmw	29	15	to	to	IN
cord-301921-i1o18nmw	29	16	their	-PRON-	PRP$
cord-301921-i1o18nmw	29	17	targetoid	targetoid	JJ
cord-301921-i1o18nmw	29	18	shape	shape	NN
cord-301921-i1o18nmw	29	19	and	and	CC
cord-301921-i1o18nmw	29	20	peculiar	peculiar	JJ
cord-301921-i1o18nmw	29	21	distribution	distribution	NN
cord-301921-i1o18nmw	29	22	.	.	.
cord-301921-i1o18nmw	30	1	Considering	consider	VBG
cord-301921-i1o18nmw	30	2	the	the	DT
cord-301921-i1o18nmw	30	3	latest	late	JJS
cord-301921-i1o18nmw	30	4	reports	report	NNS
cord-301921-i1o18nmw	30	5	from	from	IN
cord-301921-i1o18nmw	30	6	our	-PRON-	PRP$
cord-301921-i1o18nmw	30	7	country	country	NN
cord-301921-i1o18nmw	30	8	(	(	-LRB-
cord-301921-i1o18nmw	30	9	9	9	CD
cord-301921-i1o18nmw	30	10	)	)	-RRB-
cord-301921-i1o18nmw	30	11	,	,	,
cord-301921-i1o18nmw	30	12	it	-PRON-	PRP
cord-301921-i1o18nmw	30	13	is	be	VBZ
cord-301921-i1o18nmw	30	14	reasonable	reasonable	JJ
cord-301921-i1o18nmw	30	15	that	that	IN
cord-301921-i1o18nmw	30	16	these	these	DT
cord-301921-i1o18nmw	30	17	acral	acral	JJ
cord-301921-i1o18nmw	30	18	lesions	lesion	NNS
cord-301921-i1o18nmw	30	19	could	could	MD
cord-301921-i1o18nmw	30	20	be	be	VB
cord-301921-i1o18nmw	30	21	interpreted	interpret	VBN
cord-301921-i1o18nmw	30	22	as	as	IN
cord-301921-i1o18nmw	30	23	signs	sign	NNS
cord-301921-i1o18nmw	30	24	of	of	IN
cord-301921-i1o18nmw	30	25	acral	acral	JJ
cord-301921-i1o18nmw	30	26	ischemia	ischemia	NN
cord-301921-i1o18nmw	30	27	secondary	secondary	JJ
cord-301921-i1o18nmw	30	28	to	to	IN
cord-301921-i1o18nmw	30	29	a	a	DT
cord-301921-i1o18nmw	30	30	possible	possible	JJ
cord-301921-i1o18nmw	30	31	virally	virally	RB
cord-301921-i1o18nmw	30	32	induced	induce	VBN
cord-301921-i1o18nmw	30	33	vasculitis	vasculitis	NN
cord-301921-i1o18nmw	30	34	.	.	.
cord-301921-i1o18nmw	31	1	A	a	DT
cord-301921-i1o18nmw	31	2	Chinese	chinese	JJ
cord-301921-i1o18nmw	31	3	autoptic	autoptic	JJ
cord-301921-i1o18nmw	31	4	study	study	NN
cord-301921-i1o18nmw	31	5	provided	provide	VBD
cord-301921-i1o18nmw	31	6	some	some	DT
cord-301921-i1o18nmw	31	7	preliminary	preliminary	JJ
cord-301921-i1o18nmw	31	8	evidence	evidence	NN
cord-301921-i1o18nmw	31	9	from	from	IN
cord-301921-i1o18nmw	31	10	skin	skin	NN
cord-301921-i1o18nmw	31	11	samples	sample	NNS
cord-301921-i1o18nmw	31	12	of	of	IN
cord-301921-i1o18nmw	31	13	three	three	CD
cord-301921-i1o18nmw	31	14	COVID-19	covid-19	CD
cord-301921-i1o18nmw	31	15	patients	patient	NNS
cord-301921-i1o18nmw	31	16	,	,	,
cord-301921-i1o18nmw	31	17	supporting	support	VBG
cord-301921-i1o18nmw	31	18	cutaneous	cutaneous	JJ
cord-301921-i1o18nmw	31	19	disease	disease	NN
cord-301921-i1o18nmw	31	20	involvement	involvement	NN
cord-301921-i1o18nmw	31	21	(	(	-LRB-
cord-301921-i1o18nmw	31	22	10	10	CD
cord-301921-i1o18nmw	31	23	)	)	-RRB-
cord-301921-i1o18nmw	31	24	.	.	.
cord-301921-i1o18nmw	32	1	Inflammatory	inflammatory	JJ
cord-301921-i1o18nmw	32	2	damage	damage	NN
cord-301921-i1o18nmw	32	3	was	be	VBD
cord-301921-i1o18nmw	32	4	reported	report	VBN
cord-301921-i1o18nmw	32	5	without	without	IN
cord-301921-i1o18nmw	32	6	evidence	evidence	NN
cord-301921-i1o18nmw	32	7	of	of	IN
cord-301921-i1o18nmw	32	8	viral	viral	JJ
cord-301921-i1o18nmw	32	9	epidermal	epidermal	JJ
cord-301921-i1o18nmw	32	10	tropism	tropism	NN
cord-301921-i1o18nmw	32	11	,	,	,
cord-301921-i1o18nmw	32	12	hinting	hint	VBG
cord-301921-i1o18nmw	32	13	at	at	IN
cord-301921-i1o18nmw	32	14	an	an	DT
cord-301921-i1o18nmw	32	15	immune	immune	NN
cord-301921-i1o18nmw	32	16	-	-	HYPH
cord-301921-i1o18nmw	32	17	mediated	mediate	VBN
cord-301921-i1o18nmw	32	18	reaction	reaction	NN
cord-301921-i1o18nmw	32	19	targeting	target	VBG
cord-301921-i1o18nmw	32	20	this	this	DT
cord-301921-i1o18nmw	32	21	district	district	NN
cord-301921-i1o18nmw	32	22	that	that	WDT
cord-301921-i1o18nmw	32	23	is	be	VBZ
cord-301921-i1o18nmw	32	24	not	not	RB
cord-301921-i1o18nmw	32	25	related	relate	VBN
cord-301921-i1o18nmw	32	26	to	to	IN
cord-301921-i1o18nmw	32	27	the	the	DT
cord-301921-i1o18nmw	32	28	presence	presence	NN
cord-301921-i1o18nmw	32	29	of	of	IN
cord-301921-i1o18nmw	32	30	SARS	SARS	NNP
cord-301921-i1o18nmw	32	31	-	-	HYPH
cord-301921-i1o18nmw	32	32	CoV-2	CoV-2	NNP
cord-301921-i1o18nmw	32	33	in	in	IN
cord-301921-i1o18nmw	32	34	the	the	DT
cord-301921-i1o18nmw	32	35	skin	skin	NN
cord-301921-i1o18nmw	32	36	.	.	.
cord-301921-i1o18nmw	33	1	A	a	DT
cord-301921-i1o18nmw	33	2	dermatopathologist	dermatopathologist	NN
cord-301921-i1o18nmw	33	3	from	from	IN
cord-301921-i1o18nmw	33	4	our	-PRON-	PRP$
cord-301921-i1o18nmw	33	5	country	country	NN
cord-301921-i1o18nmw	33	6	has	have	VBZ
cord-301921-i1o18nmw	33	7	shared	share	VBN
cord-301921-i1o18nmw	33	8	the	the	DT
cord-301921-i1o18nmw	33	9	report	report	NN
cord-301921-i1o18nmw	33	10	of	of	IN
cord-301921-i1o18nmw	33	11	skin	skin	NN
cord-301921-i1o18nmw	33	12	biopsies	biopsy	NNS
cord-301921-i1o18nmw	33	13	performed	perform	VBN
cord-301921-i1o18nmw	33	14	on	on	IN
cord-301921-i1o18nmw	33	15	two	two	CD
cord-301921-i1o18nmw	33	16	patients	patient	NNS
cord-301921-i1o18nmw	33	17	with	with	IN
cord-301921-i1o18nmw	33	18	COVID-19	COVID-19	NNP
cord-301921-i1o18nmw	33	19	disease	disease	NN
cord-301921-i1o18nmw	33	20	,	,	,
cord-301921-i1o18nmw	33	21	matching	match	VBG
cord-301921-i1o18nmw	33	22	the	the	DT
cord-301921-i1o18nmw	33	23	histology	histology	NN
cord-301921-i1o18nmw	33	24	of	of	IN
cord-301921-i1o18nmw	33	25	Giannotti	Giannotti	NNP
cord-301921-i1o18nmw	33	26	-	-	HYPH
cord-301921-i1o18nmw	33	27	Crosti	Crosti	NNP
cord-301921-i1o18nmw	33	28	syndrome	syndrome	NN
cord-301921-i1o18nmw	33	29	,	,	,
cord-301921-i1o18nmw	33	30	that	that	RB
cord-301921-i1o18nmw	33	31	is	be	VBZ
cord-301921-i1o18nmw	33	32	a	a	DT
cord-301921-i1o18nmw	33	33	non	non	JJ
cord-301921-i1o18nmw	33	34	-	-	JJ
cord-301921-i1o18nmw	33	35	specific	specific	JJ
cord-301921-i1o18nmw	33	36	manifestation	manifestation	NN
cord-301921-i1o18nmw	33	37	of	of	IN
cord-301921-i1o18nmw	33	38	a	a	DT
cord-301921-i1o18nmw	33	39	viral	viral	JJ
cord-301921-i1o18nmw	33	40	infection	infection	NN
cord-301921-i1o18nmw	33	41	(	(	-LRB-
cord-301921-i1o18nmw	33	42	11	11	CD
cord-301921-i1o18nmw	33	43	)	)	-RRB-
cord-301921-i1o18nmw	33	44	.	.	.
cord-301921-i1o18nmw	34	1	Due	due	IN
cord-301921-i1o18nmw	34	2	to	to	IN
cord-301921-i1o18nmw	34	3	the	the	DT
cord-301921-i1o18nmw	34	4	unpredictable	unpredictable	JJ
cord-301921-i1o18nmw	34	5	rate	rate	NN
cord-301921-i1o18nmw	34	6	of	of	IN
cord-301921-i1o18nmw	34	7	asymptomatic	asymptomatic	JJ
cord-301921-i1o18nmw	34	8	carriers	carrier	NNS
cord-301921-i1o18nmw	34	9	in	in	IN
cord-301921-i1o18nmw	34	10	this	this	DT
cord-301921-i1o18nmw	34	11	stage	stage	NN
cord-301921-i1o18nmw	34	12	it	-PRON-	PRP
cord-301921-i1o18nmw	34	13	is	be	VBZ
cord-301921-i1o18nmw	34	14	difficult	difficult	JJ
cord-301921-i1o18nmw	34	15	to	to	TO
cord-301921-i1o18nmw	34	16	speculate	speculate	VB
cord-301921-i1o18nmw	34	17	on	on	IN
cord-301921-i1o18nmw	34	18	the	the	DT
cord-301921-i1o18nmw	34	19	proportion	proportion	NN
cord-301921-i1o18nmw	34	20	of	of	IN
cord-301921-i1o18nmw	34	21	subjects	subject	NNS
cord-301921-i1o18nmw	34	22	with	with	IN
cord-301921-i1o18nmw	34	23	COVID-19-related	covid-19-related	JJ
cord-301921-i1o18nmw	34	24	skin	skin	NN
cord-301921-i1o18nmw	34	25	lesions	lesion	NNS
cord-301921-i1o18nmw	34	26	.	.	.
cord-301921-i1o18nmw	35	1	However	however	RB
cord-301921-i1o18nmw	35	2	,	,	,
cord-301921-i1o18nmw	35	3	our	-PRON-	PRP$
cord-301921-i1o18nmw	35	4	observations	observation	NNS
cord-301921-i1o18nmw	35	5	occurred	occur	VBD
cord-301921-i1o18nmw	35	6	mostly	mostly	RB
cord-301921-i1o18nmw	35	7	in	in	IN
cord-301921-i1o18nmw	35	8	the	the	DT
cord-301921-i1o18nmw	35	9	month	month	NN
cord-301921-i1o18nmw	35	10	of	of	IN
cord-301921-i1o18nmw	35	11	March	March	NNP
cord-301921-i1o18nmw	35	12	and	and	CC
cord-301921-i1o18nmw	35	13	their	-PRON-	PRP$
cord-301921-i1o18nmw	35	14	incidence	incidence	NN
cord-301921-i1o18nmw	35	15	apparently	apparently	RB
cord-301921-i1o18nmw	35	16	decreased	decrease	VBD
cord-301921-i1o18nmw	35	17	over	over	IN
cord-301921-i1o18nmw	35	18	April	April	NNP
cord-301921-i1o18nmw	35	19	,	,	,
cord-301921-i1o18nmw	35	20	possibly	possibly	RB
cord-301921-i1o18nmw	35	21	reflecting	reflect	VBG
cord-301921-i1o18nmw	35	22	the	the	DT
cord-301921-i1o18nmw	35	23	concurrent	concurrent	JJ
cord-301921-i1o18nmw	35	24	decline	decline	NN
cord-301921-i1o18nmw	35	25	in	in	IN
cord-301921-i1o18nmw	35	26	the	the	DT
cord-301921-i1o18nmw	35	27	transmission	transmission	NN
cord-301921-i1o18nmw	35	28	of	of	IN
cord-301921-i1o18nmw	35	29	SARS	SARS	NNP
cord-301921-i1o18nmw	35	30	-	-	HYPH
cord-301921-i1o18nmw	35	31	CoV-2	CoV-2	NNP
cord-301921-i1o18nmw	35	32	in	in	IN
cord-301921-i1o18nmw	35	33	our	-PRON-	PRP$
cord-301921-i1o18nmw	35	34	area	area	NN
cord-301921-i1o18nmw	35	35	.	.	.
cord-301921-i1o18nmw	36	1	In	in	IN
cord-301921-i1o18nmw	36	2	the	the	DT
cord-301921-i1o18nmw	36	3	current	current	JJ
cord-301921-i1o18nmw	36	4	outbreak	outbreak	NN
cord-301921-i1o18nmw	36	5	,	,	,
cord-301921-i1o18nmw	36	6	and	and	CC
cord-301921-i1o18nmw	36	7	considering	consider	VBG
cord-301921-i1o18nmw	36	8	the	the	DT
cord-301921-i1o18nmw	36	9	predicted	predict	VBN
cord-301921-i1o18nmw	36	10	high	high	JJ
cord-301921-i1o18nmw	36	11	rate	rate	NN
cord-301921-i1o18nmw	36	12	of	of	IN
cord-301921-i1o18nmw	36	13	asymptomatic	asymptomatic	JJ
cord-301921-i1o18nmw	36	14	cases	case	NNS
cord-301921-i1o18nmw	36	15	,	,	,
cord-301921-i1o18nmw	36	16	we	-PRON-	PRP
cord-301921-i1o18nmw	36	17	wondered	wonder	VBD
cord-301921-i1o18nmw	36	18	if	if	IN
cord-301921-i1o18nmw	36	19	these	these	DT
cord-301921-i1o18nmw	36	20	cases	case	NNS
cord-301921-i1o18nmw	36	21	should	should	MD
cord-301921-i1o18nmw	36	22	be	be	VB
cord-301921-i1o18nmw	36	23	tested	test	VBN
cord-301921-i1o18nmw	36	24	for	for	IN
cord-301921-i1o18nmw	36	25	the	the	DT
cord-301921-i1o18nmw	36	26	presence	presence	NN
cord-301921-i1o18nmw	36	27	of	of	IN
cord-301921-i1o18nmw	36	28	novel	novel	NN
cord-301921-i1o18nmw	36	29	SARS	SARS	NNP
cord-301921-i1o18nmw	36	30	-	-	HYPH
cord-301921-i1o18nmw	36	31	CoV-2	CoV-2	NNP
cord-301921-i1o18nmw	36	32	,	,	,
cord-301921-i1o18nmw	36	33	as	as	IN
cord-301921-i1o18nmw	36	34	the	the	DT
cord-301921-i1o18nmw	36	35	serology	serology	NN
cord-301921-i1o18nmw	36	36	to	to	IN
cord-301921-i1o18nmw	36	37	commonly	commonly	RB
cord-301921-i1o18nmw	36	38	associated	associate	VBN
cord-301921-i1o18nmw	36	39	viral	viral	JJ
cord-301921-i1o18nmw	36	40	agents	agent	NNS
cord-301921-i1o18nmw	36	41	is	be	VBZ
cord-301921-i1o18nmw	36	42	negative	negative	JJ
cord-301921-i1o18nmw	36	43	.	.	.
cord-301921-i1o18nmw	37	1	However	however	RB
cord-301921-i1o18nmw	37	2	,	,	,
cord-301921-i1o18nmw	37	3	due	due	IN
cord-301921-i1o18nmw	37	4	to	to	IN
cord-301921-i1o18nmw	37	5	a	a	DT
cord-301921-i1o18nmw	37	6	current	current	JJ
cord-301921-i1o18nmw	37	7	shortage	shortage	NN
cord-301921-i1o18nmw	37	8	of	of	IN
cord-301921-i1o18nmw	37	9	diagnostic	diagnostic	JJ
cord-301921-i1o18nmw	37	10	tests	test	NNS
cord-301921-i1o18nmw	37	11	related	relate	VBN
cord-301921-i1o18nmw	37	12	to	to	IN
cord-301921-i1o18nmw	37	13	an	an	DT
cord-301921-i1o18nmw	37	14	ongoing	ongoing	JJ
cord-301921-i1o18nmw	37	15	emergency	emergency	NN
cord-301921-i1o18nmw	37	16	we	-PRON-	PRP
cord-301921-i1o18nmw	37	17	could	could	MD
cord-301921-i1o18nmw	37	18	not	not	RB
cord-301921-i1o18nmw	37	19	perform	perform	VB
cord-301921-i1o18nmw	37	20	a	a	DT
cord-301921-i1o18nmw	37	21	diagnosis	diagnosis	NN
cord-301921-i1o18nmw	37	22	of	of	IN
cord-301921-i1o18nmw	37	23	SARS	SARS	NNP
cord-301921-i1o18nmw	37	24	-	-	HYPH
cord-301921-i1o18nmw	37	25	CoV-2	CoV-2	NNP
cord-301921-i1o18nmw	37	26	infection	infection	NN
cord-301921-i1o18nmw	37	27	.	.	.
cord-301921-i1o18nmw	38	1	It	-PRON-	PRP
cord-301921-i1o18nmw	38	2	is	be	VBZ
cord-301921-i1o18nmw	38	3	remarkable	remarkable	JJ
cord-301921-i1o18nmw	38	4	to	to	TO
cord-301921-i1o18nmw	38	5	notice	notice	VB
cord-301921-i1o18nmw	38	6	that	that	IN
cord-301921-i1o18nmw	38	7	these	these	DT
cord-301921-i1o18nmw	38	8	virally	virally	RB
cord-301921-i1o18nmw	38	9	induced	induce	VBN
cord-301921-i1o18nmw	38	10	immunemediated	immunemediated	JJ
cord-301921-i1o18nmw	38	11	skin	skin	NN
cord-301921-i1o18nmw	38	12	eruptions	eruption	NNS
cord-301921-i1o18nmw	38	13	apparently	apparently	RB
cord-301921-i1o18nmw	38	14	occur	occur	VBP
cord-301921-i1o18nmw	38	15	in	in	IN
cord-301921-i1o18nmw	38	16	patients	patient	NNS
cord-301921-i1o18nmw	38	17	that	that	WDT
cord-301921-i1o18nmw	38	18	have	have	VBP
cord-301921-i1o18nmw	38	19	negligible	negligible	JJ
cord-301921-i1o18nmw	38	20	symptoms	symptom	NNS
cord-301921-i1o18nmw	38	21	of	of	IN
cord-301921-i1o18nmw	38	22	a	a	DT
cord-301921-i1o18nmw	38	23	systemic	systemic	JJ
cord-301921-i1o18nmw	38	24	viral	viral	JJ
cord-301921-i1o18nmw	38	25	disease	disease	NN
cord-301921-i1o18nmw	38	26	.	.	.
cord-301921-i1o18nmw	39	1	These	these	DT
cord-301921-i1o18nmw	39	2	observations	observation	NNS
cord-301921-i1o18nmw	39	3	hint	hint	VBP
cord-301921-i1o18nmw	39	4	at	at	IN
cord-301921-i1o18nmw	39	5	the	the	DT
cord-301921-i1o18nmw	39	6	possible	possible	JJ
cord-301921-i1o18nmw	39	7	role	role	NN
cord-301921-i1o18nmw	39	8	of	of	IN
cord-301921-i1o18nmw	39	9	specific	specific	JJ
cord-301921-i1o18nmw	39	10	genetic	genetic	JJ
cord-301921-i1o18nmw	39	11	factors	factor	NNS
cord-301921-i1o18nmw	39	12	that	that	WDT
cord-301921-i1o18nmw	39	13	,	,	,
cord-301921-i1o18nmw	39	14	while	while	IN
cord-301921-i1o18nmw	39	15	a	a	DT
cord-301921-i1o18nmw	39	16	predisposition	predisposition	NN
cord-301921-i1o18nmw	39	17	to	to	IN
cord-301921-i1o18nmw	39	18	the	the	DT
cord-301921-i1o18nmw	39	19	development	development	NN
cord-301921-i1o18nmw	39	20	of	of	IN
cord-301921-i1o18nmw	39	21	skin	skin	NN
cord-301921-i1o18nmw	39	22	eruptions	eruption	NNS
cord-301921-i1o18nmw	39	23	,	,	,
cord-301921-i1o18nmw	39	24	may	may	MD
cord-301921-i1o18nmw	39	25	protect	protect	VB
cord-301921-i1o18nmw	39	26	from	from	IN
cord-301921-i1o18nmw	39	27	severely	severely	RB
cord-301921-i1o18nmw	39	28	symptomatic	symptomatic	JJ
cord-301921-i1o18nmw	39	29	presentations	presentation	NNS
cord-301921-i1o18nmw	39	30	of	of	IN
cord-301921-i1o18nmw	39	31	coronavirus	coronavirus	NN
cord-301921-i1o18nmw	39	32	infection	infection	NN
cord-301921-i1o18nmw	39	33	.	.	.
cord-301921-i1o18nmw	40	1	In	in	IN
cord-301921-i1o18nmw	40	2	our	-PRON-	PRP$
cord-301921-i1o18nmw	40	3	current	current	JJ
cord-301921-i1o18nmw	40	4	cases	case	NNS
cord-301921-i1o18nmw	40	5	of	of	IN
cord-301921-i1o18nmw	40	6	atypical	atypical	JJ
cord-301921-i1o18nmw	40	7	skin	skin	NN
cord-301921-i1o18nmw	40	8	eruptions	eruption	NNS
cord-301921-i1o18nmw	40	9	,	,	,
cord-301921-i1o18nmw	40	10	in	in	IN
cord-301921-i1o18nmw	40	11	which	which	WDT
cord-301921-i1o18nmw	40	12	a	a	DT
cord-301921-i1o18nmw	40	13	relationship	relationship	NN
cord-301921-i1o18nmw	40	14	with	with	IN
cord-301921-i1o18nmw	40	15	conventional	conventional	JJ
cord-301921-i1o18nmw	40	16	viral	viral	JJ
cord-301921-i1o18nmw	40	17	agents	agent	NNS
cord-301921-i1o18nmw	40	18	has	have	VBZ
cord-301921-i1o18nmw	40	19	been	be	VBN
cord-301921-i1o18nmw	40	20	ruled	rule	VBN
cord-301921-i1o18nmw	40	21	out	out	RP
cord-301921-i1o18nmw	40	22	by	by	IN
cord-301921-i1o18nmw	40	23	laboratory	laboratory	NN
cord-301921-i1o18nmw	40	24	testing	testing	NN
cord-301921-i1o18nmw	40	25	and	and	CC
cord-301921-i1o18nmw	40	26	clinical	clinical	JJ
cord-301921-i1o18nmw	40	27	history	history	NN
cord-301921-i1o18nmw	40	28	,	,	,
cord-301921-i1o18nmw	40	29	molecular	molecular	JJ
cord-301921-i1o18nmw	40	30	testing	testing	NN
cord-301921-i1o18nmw	40	31	with	with	IN
cord-301921-i1o18nmw	40	32	PCR	PCR	NNP
cord-301921-i1o18nmw	40	33	could	could	MD
cord-301921-i1o18nmw	40	34	be	be	VB
cord-301921-i1o18nmw	40	35	performed	perform	VBN
cord-301921-i1o18nmw	40	36	on	on	IN
cord-301921-i1o18nmw	40	37	pharynx	pharynx	NN
cord-301921-i1o18nmw	40	38	swabs	swab	NNS
cord-301921-i1o18nmw	40	39	to	to	TO
cord-301921-i1o18nmw	40	40	support	support	VB
cord-301921-i1o18nmw	40	41	the	the	DT
cord-301921-i1o18nmw	40	42	hypothesis	hypothesis	NN
cord-301921-i1o18nmw	40	43	of	of	IN
cord-301921-i1o18nmw	40	44	a	a	DT
cord-301921-i1o18nmw	40	45	possible	possible	JJ
cord-301921-i1o18nmw	40	46	association	association	NN
cord-301921-i1o18nmw	40	47	with	with	IN
cord-301921-i1o18nmw	40	48	the	the	DT
cord-301921-i1o18nmw	40	49	novel	novel	JJ
cord-301921-i1o18nmw	40	50	coronavirus	coronavirus	NN
cord-301921-i1o18nmw	40	51	.	.	.
cord-301921-i1o18nmw	41	1	Forthcoming	forthcoming	JJ
cord-301921-i1o18nmw	41	2	rapid	rapid	JJ
cord-301921-i1o18nmw	41	3	and	and	CC
cord-301921-i1o18nmw	41	4	specific	specific	JJ
cord-301921-i1o18nmw	41	5	serum	serum	NN
cord-301921-i1o18nmw	41	6	assays	assay	NNS
cord-301921-i1o18nmw	41	7	are	be	VBP
cord-301921-i1o18nmw	41	8	expected	expect	VBN
cord-301921-i1o18nmw	41	9	to	to	TO
cord-301921-i1o18nmw	41	10	aid	aid	VB
cord-301921-i1o18nmw	41	11	in	in	IN
cord-301921-i1o18nmw	41	12	the	the	DT
cord-301921-i1o18nmw	41	13	identification	identification	NN
cord-301921-i1o18nmw	41	14	of	of	IN
cord-301921-i1o18nmw	41	15	asymptomatic	asymptomatic	JJ
cord-301921-i1o18nmw	41	16	carriers	carrier	NNS
cord-301921-i1o18nmw	41	17	,	,	,
cord-301921-i1o18nmw	41	18	which	which	WDT
cord-301921-i1o18nmw	41	19	is	be	VBZ
cord-301921-i1o18nmw	41	20	key	key	JJ
cord-301921-i1o18nmw	41	21	to	to	IN
cord-301921-i1o18nmw	41	22	controlling	control	VBG
cord-301921-i1o18nmw	41	23	the	the	DT
cord-301921-i1o18nmw	41	24	spread	spread	NN
cord-301921-i1o18nmw	41	25	of	of	IN
cord-301921-i1o18nmw	41	26	disease	disease	NN
cord-301921-i1o18nmw	41	27	.	.	.
cord-301921-i1o18nmw	42	1	In	in	IN
cord-301921-i1o18nmw	42	2	conclusion	conclusion	NN
cord-301921-i1o18nmw	42	3	,	,	,
cord-301921-i1o18nmw	42	4	highlighting	highlight	VBG
cord-301921-i1o18nmw	42	5	a	a	DT
cord-301921-i1o18nmw	42	6	relationship	relationship	NN
cord-301921-i1o18nmw	42	7	between	between	IN
cord-301921-i1o18nmw	42	8	SARS	SARS	NNP
cord-301921-i1o18nmw	42	9	-	-	HYPH
cord-301921-i1o18nmw	42	10	CoV-2	CoV-2	NNP
cord-301921-i1o18nmw	42	11	and	and	CC
cord-301921-i1o18nmw	42	12	virus	virus	NN
cord-301921-i1o18nmw	42	13	-	-	HYPH
cord-301921-i1o18nmw	42	14	induced	induce	VBN
cord-301921-i1o18nmw	42	15	skin	skin	NN
cord-301921-i1o18nmw	42	16	conditions	condition	NNS
cord-301921-i1o18nmw	42	17	may	may	MD
cord-301921-i1o18nmw	42	18	help	help	VB
cord-301921-i1o18nmw	42	19	identify	identify	VB
cord-301921-i1o18nmw	42	20	asymptomatic	asymptomatic	JJ
cord-301921-i1o18nmw	42	21	carriers	carrier	NNS
cord-301921-i1o18nmw	42	22	that	that	WDT
cord-301921-i1o18nmw	42	23	are	be	VBP
cord-301921-i1o18nmw	42	24	a	a	DT
cord-301921-i1o18nmw	42	25	critical	critical	JJ
cord-301921-i1o18nmw	42	26	source	source	NN
cord-301921-i1o18nmw	42	27	of	of	IN
cord-301921-i1o18nmw	42	28	inter	inter	JJ
cord-301921-i1o18nmw	42	29	-	-	JJ
cord-301921-i1o18nmw	42	30	human	human	JJ
cord-301921-i1o18nmw	42	31	transmission	transmission	NN
cord-301921-i1o18nmw	42	32	.	.	.
cord-301921-i1o18nmw	43	1	The	the	DT
cord-301921-i1o18nmw	43	2	SARS	SARS	NNP
cord-301921-i1o18nmw	43	3	,	,	,
cord-301921-i1o18nmw	43	4	MERS	MERS	NNP
cord-301921-i1o18nmw	43	5	and	and	CC
cord-301921-i1o18nmw	43	6	novel	novel	JJ
cord-301921-i1o18nmw	43	7	coronavirus	coronavirus	NN
cord-301921-i1o18nmw	43	8	(	(	-LRB-
cord-301921-i1o18nmw	43	9	COVID-19	COVID-19	NNP
cord-301921-i1o18nmw	43	10	)	)	-RRB-
cord-301921-i1o18nmw	43	11	epidemics	epidemic	NNS
cord-301921-i1o18nmw	43	12	,	,	,
cord-301921-i1o18nmw	43	13	the	the	DT
cord-301921-i1o18nmw	43	14	newest	new	JJS
cord-301921-i1o18nmw	43	15	and	and	CC
cord-301921-i1o18nmw	43	16	biggest	big	JJS
cord-301921-i1o18nmw	43	17	global	global	JJ
cord-301921-i1o18nmw	43	18	health	health	NN
cord-301921-i1o18nmw	43	19	threats	threat	NNS
cord-301921-i1o18nmw	43	20	:	:	:
cord-301921-i1o18nmw	43	21	what	what	WDT
cord-301921-i1o18nmw	43	22	lessons	lesson	NNS
cord-301921-i1o18nmw	43	23	have	have	VBP
cord-301921-i1o18nmw	43	24	we	-PRON-	PRP
cord-301921-i1o18nmw	43	25	learned	learn	VBN
cord-301921-i1o18nmw	43	26	?	?	.
cord-301921-i1o18nmw	44	1	Development	development	NN
cord-301921-i1o18nmw	44	2	and	and	CC
cord-301921-i1o18nmw	44	3	clinical	clinical	JJ
cord-301921-i1o18nmw	44	4	application	application	NN
cord-301921-i1o18nmw	44	5	of	of	IN
cord-301921-i1o18nmw	44	6	a	a	DT
cord-301921-i1o18nmw	44	7	rapid	rapid	JJ
cord-301921-i1o18nmw	44	8	IgM	IgM	NNP
cord-301921-i1o18nmw	44	9	-	-	HYPH
cord-301921-i1o18nmw	44	10	IgG	IgG	NNP
cord-301921-i1o18nmw	44	11	combined	combine	VBN
cord-301921-i1o18nmw	44	12	antibody	antibody	NN
cord-301921-i1o18nmw	44	13	test	test	NN
cord-301921-i1o18nmw	44	14	for	for	IN
cord-301921-i1o18nmw	44	15	SARS	SARS	NNP
cord-301921-i1o18nmw	44	16	-	-	HYPH
cord-301921-i1o18nmw	44	17	CoV-2	CoV-2	NNP
cord-301921-i1o18nmw	44	18	infection	infection	NN
cord-301921-i1o18nmw	44	19	diagnosis	diagnosis	NN
cord-301921-i1o18nmw	44	20	Emergency	emergency	NN
cord-301921-i1o18nmw	44	21	management	management	NN
cord-301921-i1o18nmw	44	22	for	for	IN
cord-301921-i1o18nmw	44	23	preventing	prevent	VBG
cord-301921-i1o18nmw	44	24	and	and	CC
cord-301921-i1o18nmw	44	25	controlling	control	VBG
cord-301921-i1o18nmw	44	26	nosocomial	nosocomial	JJ
cord-301921-i1o18nmw	44	27	infection	infection	NN
cord-301921-i1o18nmw	44	28	of	of	IN
cord-301921-i1o18nmw	44	29	2019	2019	CD
cord-301921-i1o18nmw	44	30	novel	novel	JJ
cord-301921-i1o18nmw	44	31	coronavirus	coronavirus	NN
cord-301921-i1o18nmw	44	32	:	:	:
cord-301921-i1o18nmw	44	33	implications	implication	NNS
cord-301921-i1o18nmw	44	34	for	for	IN
cord-301921-i1o18nmw	44	35	the	the	DT
cord-301921-i1o18nmw	44	36	dermatology	dermatology	NNP
cord-301921-i1o18nmw	44	37	department	department	NN
cord-301921-i1o18nmw	45	1	Available	available	JJ
cord-301921-i1o18nmw	45	2	online	online	RB
cord-301921-i1o18nmw	45	3	at	at	IN
cord-301921-i1o18nmw	45	4	Clinical	clinical	JJ
cord-301921-i1o18nmw	45	5	characteristics	characteristic	NNS
cord-301921-i1o18nmw	45	6	of	of	IN
cord-301921-i1o18nmw	45	7	coronavirus	coronavirus	NN
cord-301921-i1o18nmw	45	8	disease	disease	NN
cord-301921-i1o18nmw	45	9	2019	2019	CD
cord-301921-i1o18nmw	45	10	in	in	IN
cord-301921-i1o18nmw	45	11	China	China	NNP
cord-301921-i1o18nmw	45	12	Early	early	JJ
cord-301921-i1o18nmw	45	13	transmission	transmission	NN
cord-301921-i1o18nmw	45	14	dynamics	dynamic	NNS
cord-301921-i1o18nmw	45	15	in	in	IN
cord-301921-i1o18nmw	45	16	Wuhan	Wuhan	NNP
cord-301921-i1o18nmw	45	17	,	,	,
cord-301921-i1o18nmw	45	18	China	China	NNP
cord-301921-i1o18nmw	45	19	,	,	,
cord-301921-i1o18nmw	45	20	of	of	IN
cord-301921-i1o18nmw	45	21	novel	novel	JJ
cord-301921-i1o18nmw	45	22	coronavirus	coronavirus	NN
cord-301921-i1o18nmw	45	23	-	-	HYPH
cord-301921-i1o18nmw	45	24	infected	infect	VBN
cord-301921-i1o18nmw	45	25	pneumonia	pneumonia	NN
cord-301921-i1o18nmw	45	26	Cutaneous	cutaneous	JJ
cord-301921-i1o18nmw	45	27	manifestations	manifestation	NNS
cord-301921-i1o18nmw	45	28	in	in	IN
cord-301921-i1o18nmw	45	29	COVID-19	COVID-19	NNP
cord-301921-i1o18nmw	45	30	:	:	:
cord-301921-i1o18nmw	45	31	a	a	DT
cord-301921-i1o18nmw	45	32	first	first	JJ
cord-301921-i1o18nmw	45	33	perspective	perspective	NN
cord-301921-i1o18nmw	45	34	Available	available	JJ
cord-301921-i1o18nmw	45	35	online	online	RB
cord-301921-i1o18nmw	45	36	at	at	IN
cord-301921-i1o18nmw	45	37	MA	MA	NNP
cord-301921-i1o18nmw	45	38	conceived	conceive	VBD
cord-301921-i1o18nmw	45	39	the	the	DT
cord-301921-i1o18nmw	45	40	idea	idea	NN
cord-301921-i1o18nmw	45	41	.	.	.
cord-301921-i1o18nmw	46	1	AS	as	IN
cord-301921-i1o18nmw	46	2	designed	design	VBN
cord-301921-i1o18nmw	46	3	and	and	CC
cord-301921-i1o18nmw	46	4	drafted	draft	VBD
cord-301921-i1o18nmw	46	5	the	the	DT
cord-301921-i1o18nmw	46	6	manuscript	manuscript	NN
cord-301921-i1o18nmw	46	7	.	.	.
cord-301921-i1o18nmw	47	1	All	all	DT
cord-301921-i1o18nmw	47	2	authors	author	NNS
cord-301921-i1o18nmw	47	3	contributed	contribute	VBD
cord-301921-i1o18nmw	47	4	to	to	IN
cord-301921-i1o18nmw	47	5	the	the	DT
cord-301921-i1o18nmw	47	6	writing	writing	NN
cord-301921-i1o18nmw	47	7	of	of	IN
cord-301921-i1o18nmw	47	8	the	the	DT
cord-301921-i1o18nmw	47	9	final	final	JJ
cord-301921-i1o18nmw	47	10	version	version	NN
cord-301921-i1o18nmw	47	11	of	of	IN
cord-301921-i1o18nmw	47	12	the	the	DT
cord-301921-i1o18nmw	47	13	article	article	NN
cord-301921-i1o18nmw	47	14	.	.	.
cord-301921-i1o18nmw	48	1	The	the	DT
cord-301921-i1o18nmw	48	2	authors	author	NNS
cord-301921-i1o18nmw	48	3	declare	declare	VBP
cord-301921-i1o18nmw	48	4	that	that	IN
cord-301921-i1o18nmw	48	5	the	the	DT
cord-301921-i1o18nmw	48	6	research	research	NN
cord-301921-i1o18nmw	48	7	was	be	VBD
cord-301921-i1o18nmw	48	8	conducted	conduct	VBN
cord-301921-i1o18nmw	48	9	in	in	IN
cord-301921-i1o18nmw	48	10	the	the	DT
cord-301921-i1o18nmw	48	11	absence	absence	NN
cord-301921-i1o18nmw	48	12	of	of	IN
cord-301921-i1o18nmw	48	13	any	any	DT
cord-301921-i1o18nmw	48	14	commercial	commercial	JJ
cord-301921-i1o18nmw	48	15	or	or	CC
cord-301921-i1o18nmw	48	16	financial	financial	JJ
cord-301921-i1o18nmw	48	17	relationships	relationship	NNS
cord-301921-i1o18nmw	48	18	that	that	WDT
cord-301921-i1o18nmw	48	19	could	could	MD
cord-301921-i1o18nmw	48	20	be	be	VB
cord-301921-i1o18nmw	48	21	construed	construe	VBN
cord-301921-i1o18nmw	48	22	as	as	IN
cord-301921-i1o18nmw	48	23	a	a	DT
cord-301921-i1o18nmw	48	24	potential	potential	JJ
cord-301921-i1o18nmw	48	25	conflict	conflict	NN
cord-301921-i1o18nmw	48	26	of	of	IN
cord-301921-i1o18nmw	48	27	interest	interest	NN
cord-301921-i1o18nmw	48	28	.	.	.
cord-301921-i1o18nmw	49	1	Copyright	copyright	NN
cord-301921-i1o18nmw	49	2	©	©	NNP
cord-301921-i1o18nmw	49	3	2020	2020	CD
cord-301921-i1o18nmw	49	4	Sernicola	Sernicola	NNP
cord-301921-i1o18nmw	49	5	and	and	CC
cord-301921-i1o18nmw	49	6	Alaibac	Alaibac	NNP
cord-301921-i1o18nmw	49	7	.	.	.
cord-301921-i1o18nmw	50	1	This	this	DT
cord-301921-i1o18nmw	50	2	is	be	VBZ
cord-301921-i1o18nmw	50	3	an	an	DT
cord-301921-i1o18nmw	50	4	open	open	JJ
cord-301921-i1o18nmw	50	5	-	-	HYPH
cord-301921-i1o18nmw	50	6	access	access	NN
cord-301921-i1o18nmw	50	7	article	article	NN
cord-301921-i1o18nmw	50	8	distributed	distribute	VBN
cord-301921-i1o18nmw	50	9	under	under	IN
cord-301921-i1o18nmw	50	10	the	the	DT
cord-301921-i1o18nmw	50	11	terms	term	NNS
cord-301921-i1o18nmw	50	12	of	of	IN
cord-301921-i1o18nmw	50	13	the	the	DT
cord-301921-i1o18nmw	50	14	Creative	Creative	NNP
cord-301921-i1o18nmw	50	15	Commons	Commons	NNP
cord-301921-i1o18nmw	50	16	Attribution	Attribution	NNP
cord-301921-i1o18nmw	50	17	License	License	NNP
cord-301921-i1o18nmw	50	18	(	(	-LRB-
cord-301921-i1o18nmw	50	19	CC	CC	NNP
cord-301921-i1o18nmw	50	20	BY	BY	NNP
cord-301921-i1o18nmw	50	21	)	)	-RRB-
cord-301921-i1o18nmw	50	22	.	.	.
cord-301921-i1o18nmw	51	1	The	the	DT
cord-301921-i1o18nmw	51	2	use	use	NN
cord-301921-i1o18nmw	51	3	,	,	,
cord-301921-i1o18nmw	51	4	distribution	distribution	NN
cord-301921-i1o18nmw	51	5	or	or	CC
cord-301921-i1o18nmw	51	6	reproduction	reproduction	NN
cord-301921-i1o18nmw	51	7	in	in	IN
cord-301921-i1o18nmw	51	8	other	other	JJ
cord-301921-i1o18nmw	51	9	forums	forum	NNS
cord-301921-i1o18nmw	51	10	is	be	VBZ
cord-301921-i1o18nmw	51	11	permitted	permit	VBN
cord-301921-i1o18nmw	51	12	,	,	,
cord-301921-i1o18nmw	51	13	provided	provide	VBD
cord-301921-i1o18nmw	51	14	the	the	DT
cord-301921-i1o18nmw	51	15	original	original	JJ
cord-301921-i1o18nmw	51	16	author(s	author(s	NNP
cord-301921-i1o18nmw	51	17	)	)	-RRB-
cord-301921-i1o18nmw	51	18	and	and	CC
cord-301921-i1o18nmw	51	19	the	the	DT
cord-301921-i1o18nmw	51	20	copyright	copyright	NN
cord-301921-i1o18nmw	51	21	owner(s	owner(s	NNP
cord-301921-i1o18nmw	51	22	)	)	-RRB-
cord-301921-i1o18nmw	51	23	are	be	VBP
cord-301921-i1o18nmw	51	24	credited	credit	VBN
cord-301921-i1o18nmw	51	25	and	and	CC
cord-301921-i1o18nmw	51	26	that	that	IN
cord-301921-i1o18nmw	51	27	the	the	DT
cord-301921-i1o18nmw	51	28	original	original	JJ
cord-301921-i1o18nmw	51	29	publication	publication	NN
cord-301921-i1o18nmw	51	30	in	in	IN
cord-301921-i1o18nmw	51	31	this	this	DT
cord-301921-i1o18nmw	51	32	journal	journal	NN
cord-301921-i1o18nmw	51	33	is	be	VBZ
cord-301921-i1o18nmw	51	34	cited	cite	VBN
cord-301921-i1o18nmw	51	35	,	,	,
cord-301921-i1o18nmw	51	36	in	in	IN
cord-301921-i1o18nmw	51	37	accordance	accordance	NN
cord-301921-i1o18nmw	51	38	with	with	IN
cord-301921-i1o18nmw	51	39	accepted	accepted	JJ
cord-301921-i1o18nmw	51	40	academic	academic	JJ
cord-301921-i1o18nmw	51	41	practice	practice	NN
cord-301921-i1o18nmw	51	42	.	.	.
cord-301921-i1o18nmw	52	1	No	no	DT
cord-301921-i1o18nmw	52	2	use	use	NN
cord-301921-i1o18nmw	52	3	,	,	,
cord-301921-i1o18nmw	52	4	distribution	distribution	NN
cord-301921-i1o18nmw	52	5	or	or	CC
cord-301921-i1o18nmw	52	6	reproduction	reproduction	NN
cord-301921-i1o18nmw	52	7	is	be	VBZ
cord-301921-i1o18nmw	52	8	permitted	permit	VBN
cord-301921-i1o18nmw	52	9	which	which	WDT
cord-301921-i1o18nmw	52	10	does	do	VBZ
cord-301921-i1o18nmw	52	11	not	not	RB
cord-301921-i1o18nmw	52	12	comply	comply	VB
cord-301921-i1o18nmw	52	13	with	with	IN
cord-301921-i1o18nmw	52	14	these	these	DT
cord-301921-i1o18nmw	52	15	terms	term	NNS
cord-301921-i1o18nmw	52	16	.	.	.